Related Experiment Videos
A rapid assay for von Willebrand factor.
1Department of Pathology, University of Iowa College of Medicine, Iowa City 52242.
Thrombosis Research
|August 15, 1988
Summary
This study describes a modified microtitre assay for quantifying von Willebrand Factor (vWF) in plasma. The assay uses fixed platelets and ristocetin, allowing adjustable sensitivity for vWF measurement.
Area of Science:
- Hematology
- Biochemistry
- Assay Development
Context:
- Quantifying von Willebrand Factor (vWF) is crucial for diagnosing bleeding disorders.
- Existing vWF assays have limitations in sensitivity and standardization.
- A need exists for a reproducible and adaptable method for vWF quantification.
Purpose:
- To describe a modified microtitre plate assay for quantifying von Willebrand Factor (vWF).
- To detail the use of fixed platelets and ristocetin as reagents in the assay.
- To demonstrate the adjustability of assay sensitivity through reagent concentrations and reaction time.
Summary:
- A novel microtitre plate assay is presented for vWF quantification.
- The assay utilizes formalin-fixed, frozen platelets as a substrate.
- Ristocetin and specimen are added to microtitre wells, and platelet agglutination is visually assessed, with sensitivity adjustable by varying reagent concentrations and incubation times.
Impact:
- Provides a potentially sensitive and adaptable method for vWF measurement.
- Offers a standardized approach for vWF quantification in clinical and research settings.
- Contributes to improved diagnosis and management of von Willebrand disease.